Deals
Pfizer and Allergan to Combine With Joint Value of $160 Billion
- Price is 27% premium to Allergan shares before talks public
- Read to be CEO, Saunders to be president of new Pfizer Plc
Allergan Shares Recoil in Wake $160 Billion Pfizer Deal
This article is for subscribers only.
Pfizer Inc. and Allergan Plc to combine in a record $160 billion deal, creating a drugmaking behemoth called Pfizer Plc with products from Viagra to Botox and a low-cost tax base.